These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 6549356)
1. CMF adjuvant programs at the Milan Cancer Institute. Bonadonna G; Rossi A; Tancini G; Valagussa P; Veronesi U Recent Results Cancer Res; 1984; 96():66-73. PubMed ID: 6549356 [No Abstract] [Full Text] [Related]
2. A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancer. Howell A; Rubens RD; Bush H; George WD; Howat JM; Crowther D; Sellwood RA; Hayward JL; Knight RK; Bulbrook RD Recent Results Cancer Res; 1984; 96():74-89. PubMed ID: 6396780 [No Abstract] [Full Text] [Related]
3. Adjuvant therapy of breast cancer: a Southwest Oncology Group experience. Rivkin SE; Glucksberg H; Foulkes M Recent Results Cancer Res; 1984; 96():166-74. PubMed ID: 6396770 [No Abstract] [Full Text] [Related]
4. Adjuvant programs for postmenopausal women with node-positive breast cancer: preliminary analysis of 5-year results. Rossi A; Brambilla C; Valagussa P; Bonadonna G Recent Results Cancer Res; 1984; 96():178-83. PubMed ID: 6396772 [No Abstract] [Full Text] [Related]
5. Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil--11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27/82. Senn HJ; Maibach R; Castiglione M; Jungi WF; Cavalli F; Leyvraz S; Obrecht JP; Schildknecht O; Siegenthaler P J Clin Oncol; 1997 Jul; 15(7):2502-9. PubMed ID: 9215818 [TBL] [Abstract][Full Text] [Related]
6. Significance of drug dose, timing and radiotherapy in adjuvant therapy of breast cancer. Buzdar AU; Smith TL; Marcus CE; Hortobagyi GN; Blumenschein GR Recent Results Cancer Res; 1984; 96():141-7. PubMed ID: 6396767 [No Abstract] [Full Text] [Related]
7. Tamoxifen and combination chemotherapy as adjuvant treatment in postmenopausal women with breast cancer. Wallgren A; Baral E; Beling U; Carstensen J; Friberg S; Glas U; Kaigas M; Skoog L Recent Results Cancer Res; 1984; 96():197-203. PubMed ID: 6396775 [No Abstract] [Full Text] [Related]
8. Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes. Buzzoni R; Bonadonna G; Valagussa P; Zambetti M J Clin Oncol; 1991 Dec; 9(12):2134-40. PubMed ID: 1960555 [TBL] [Abstract][Full Text] [Related]
9. Current results of the University of Arizona Adjuvant Breast Cancer trials (1974-1984). Jones SE; Brooks RJ; Takasugi BJ; Garewal HS; Giordano GF; Ketchel SJ; Jackson R; Heusinkveld RS; Kemmer SR; Moon TE Recent Results Cancer Res; 1984; 96():133-40. PubMed ID: 6396766 [No Abstract] [Full Text] [Related]
10. The use of a natural history data base to compare outcome among several trials of adjuvant chemotherapy for stage II breast cancer. Jones SE; Moon TE Recent Results Cancer Res; 1984; 96():148-54. PubMed ID: 6396768 [No Abstract] [Full Text] [Related]
11. Adjuvant chemotherapy with cyclophosphamide methotrexate and 5-fluorouracil (CMF) in stage II breast cancer in Indian patients. Shetty PA; Sarda PK; Majumdar AT; Pai VR; Shinde SR; D'Souza LJ; Pinto JM; Jussawalla DJ Indian J Cancer; 1985 Sep; 22(3):239-44. PubMed ID: 3843327 [No Abstract] [Full Text] [Related]
12. Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice? Henderson IC J Clin Oncol; 1985 Feb; 3(2):140-3. PubMed ID: 3881560 [No Abstract] [Full Text] [Related]
13. Adriamycin, vincristine, cyclophosphamide and 5-fluorouracil (AVCF) compared with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in premenopausal breast carcinoma. Personal results. Mathé G; Misset JL; Plagne R; Reizenstein P; Belpomme D; Le Mevel B; Guerrin J; Fumoleau P; Metz R; Delgado M Drugs Exp Clin Res; 1986; 12(1-3):143-5. PubMed ID: 3525068 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant systemic therapy in postoperative node-positive patients with breast carcinoma: the CALGB trial and the ECOG premenopausal trial. Tormey C Recent Results Cancer Res; 1984; 96():155-65. PubMed ID: 6396769 [No Abstract] [Full Text] [Related]
15. Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer: 8 year results. Senn HJ; Jungi WF; Amgwerd R; Hochuli E; Ammann J; Engelhart G; Heinz C; Wick A; Enderlin F; Creux G Recent Results Cancer Res; 1984; 96():90-101. PubMed ID: 6528092 [No Abstract] [Full Text] [Related]
16. [Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node-positive breast cancer]. Noël G; Mazeron JJ Cancer Radiother; 2001 Apr; 5(2):206-7. PubMed ID: 11355592 [No Abstract] [Full Text] [Related]
17. Ludwig Breast Cancer trials LBCS III and IV: adjuvant endocrine treatment in postmenopausal patients. Goldhirsch A Recent Results Cancer Res; 1984; 96():204-9. PubMed ID: 6549355 [No Abstract] [Full Text] [Related]